Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001493152-24-003521

Options or other derivatives

  • Chief Executive Officer acquired 317,236 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bagai Shaun Chief Executive Officer 2024-01-19 Grant or award · Stock Option +66,973 66,973 D: show line 1 in the form
Bagai Shaun Chief Executive Officer 2024-01-19 Grant or award · Stock Option +250,263 250,263 D: show line 2 in the form
Loading xslF345X05/ownership.xml…